Dose-Response Study to Evaluate the Effect of BKR-017 on Insulin Resistance and Other Metabolic Parameters in Type 2 Diabetes Patients
Clinical trial NCT04673656 · COMPLETED
Trial details
- NCT number
- NCT04673656
- Sponsor
- BioKier Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-18
- Primary completion
- 2022-12-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.